• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

GRAS Notices

  • Print
  • Share
  • E-mail

GRN No. 976

Sodium hyaluronate

Intended Use: Intended for use as an ingredient in fruit drinks/ades, carbonated soft drinks, candy, milk drinks, yogurt, and ready-to-eat cereals at levels ranging from 40-60 mg/serving.
Basis: Scientific procedures
Notifier: Bloomage Biotechnology Corp., Ltd.
Notifier Address: No. 678 Tianchen St., High-Tech Development Zone
Jinan, Shandong, 250101
GRAS Notice (releasable information): GRN 976 (in PDF) (5.0 MB)
Date of closure: May 24, 2021
FDA's Letter: At the notifier's request, FDA ceased to evaluate this notice (in PDF) (185 kB)